Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT06221098
Other study ID # soh-med-22-04-03
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date April 1, 2022
Est. completion date October 1, 2023

Study information

Verified date January 2024
Source Sohag University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Strabismus (or squint) is defined as the presence of misalignment between the visual axes of the 2 eyes presenting with deviation of the eyes. Strabismus is further subdivided into comitant (if the amount of misalignment between the 2 eyes remained equal in all directions of gaze) and incomitant (if the amount of misalignment varied in different directions of gaze). If the squinting eye was deviated inward, it is termed as a convergent squint or esotropia and if the squinting eye is deviated outward, it is termed as a divergent squint or exotropia. Pediatric esotropia may be congenital or acquired. Congenital esotropia is a well-defined entity with an onset prior to 6 months of age, characterised by a large stable angle, cross fixation, and a limited potential for binocular single vision. Acquired childhood esotropia may be paralytic or non-paralytic. The non-paralytic or concomitant type, which is neither congenital nor secondary to ocular pathology, can be divided into three main groups: (1) Accommodative esotropia, which may be fully accommodative, partially accommodative, or accommodative with convergence excess; (2) Non-accommodative esotropia; (3) Esotropia associated with neurological dysfunction, in particular cerebral palsy and hydrocephalus. The last group of esotropia will be excluded from our study. Pediatric strabismus must be treated early to maximize the potential for binocular vision and decrease the risk of amblyopia. Treatment goals include good vision in each eye (no amblyopia) and straight eyes (orthotropia). Both conditions are necessary to produce stereopsis, which is a third goal. Strabismus in children may result in undesirable appearance, amblyopia, impaired stereopsis, diplopia, and negative psychological effect.


Recruitment information / eligibility

Status Completed
Enrollment 40
Est. completion date October 1, 2023
Est. primary completion date April 1, 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 1 Day to 12 Years
Eligibility Inclusion Criteria: 1. Infants and children up to the age of 12 years. 2. Primary Concomitant convergent squint (1ry concomitant esotropia) 3. Candidate for surgical correction of squint Exclusion Criteria: - 1. Children with: 1. Paralytic squint 2. Consecutive esotropia 3. Any neurological disorders e.g. hydrocephalus. 4. History of previous squint surgery 5. History of previous other ocular surgery (e.g. congenital cataract & glaucoma) 2. Children who missed follow up.

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
bilateral medial rectus recession
release muuscle from its original insertion and backword inserted in sclera

Locations

Country Name City State
Egypt Sohag University hospitals Sohag

Sponsors (1)

Lead Sponsor Collaborator
Sohag University

Country where clinical trial is conducted

Egypt, 

References & Publications (4)

Mohney BG. Common forms of childhood strabismus in an incidence cohort. Am J Ophthalmol. 2007 Sep;144(3):465-7. doi: 10.1016/j.ajo.2007.06.011. — View Citation

Mulvihill A, MacCann A, Flitcroft I, O'Keefe M. Outcome in refractive accommodative esotropia. Br J Ophthalmol. 2000 Jul;84(7):746-9. doi: 10.1136/bjo.84.7.746. — View Citation

Rubin SE, Nelson LB, Wagner RS, Simon JW, Catalano RA. Infantile exotropia in healthy children. Ophthalmic Surg. 1988 Nov;19(11):792-4. doi: 10.3928/0090-4481-19881101-07. — View Citation

von Noorden GK. Bowman lecture. Current concepts of infantile esotropia. Eye (Lond). 1988;2 ( Pt 4):343-57. doi: 10.1038/eye.1988.65. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary orthotropia eye alignment 6 months
Primary residual esotropia esotropia >10PD undercorrection 6months
Primary consecuative exotropia exotropia > 10PD overcorrection 6 months
See also
  Status Clinical Trial Phase
Completed NCT00310960 - An Observational Study of Infantile, Acquired Non-accommodative, and Acquired Partially-accommodative Esotropia Phase 3